Clinical Cancer Research Prevention Award Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 13, 1362, March 1, 2007. doi: 10.1158/1078-0432.CCR-06-2313
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, S.

Molecular Pathways

Regulation of Metastases by Signal Transducer and Activator of Transcription 3 Signaling Pathway: Clinical Implications

Suyun Huang

Author's Affiliation: Departments of Neurosurgery and Cancer Biology, The University of Texas M. D. Anderson Cancer Center and Program in Cancer Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas

Requests for reprints: Suyun Huang, Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1004, Houston, TX 77030. Phone: 713-834-6232; Fax: 713-834-6257; E-mail: suhuang{at}mdanderson.org.

Numerous cytokines, growth factors, and oncogenic proteins activate signal transducer and activator of transcription 3 (Stat3), which has been recognized as one of the common pathways in cancer cells. Stat3 signaling affects the expression and function of a variety of genes that are critical to cell survival, cell proliferation, invasion, angiogenesis, and immune evasion. Evidently, the Stat3 signaling pathway regulates cancer metastasis and constitutes a potential preventive and therapeutic target for cancer metastasis.




This article has been cited by other articles:


Home page
Cancer Res.Home page
B. Sen, B. Saigal, N. Parikh, G. Gallick, and F. M. Johnson
Sustained Src Inhibition Results in Signal Transducer and Activator of Transcription 3 (STAT3) Activation and Cancer Cell Survival via Altered Janus-Activated Kinase-STAT3 Binding
Cancer Res., March 1, 2009; 69(5): 1958 - 1965.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Abou-Ghazal, D. S. Yang, W. Qiao, C. Reina-Ortiz, J. Wei, L.-Y. Kong, G. N. Fuller, N. Hiraoka, W. Priebe, R. Sawaya, et al.
The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas
Clin. Cancer Res., December 15, 2008; 14(24): 8228 - 8235.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Arakawa, T. Masaki, T. Hirai, S. Doi, M. Kuratsune, K. Arihiro, N. Kohno, and N. Yorioka
Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis
Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3418 - 3426.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H.-W. Lo, X. Cao, H. Zhu, and F. Ali-Osman
Constitutively Activated STAT3 Frequently Coexpresses with Epidermal Growth Factor Receptor in High-Grade Gliomas and Targeting STAT3 Sensitizes Them to Iressa and Alkylators
Clin. Cancer Res., October 1, 2008; 14(19): 6042 - 6054.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L.-Y. Kong, M. K. Abou-Ghazal, J. Wei, A. Chakraborty, W. Sun, W. Qiao, G. N. Fuller, I. Fokt, E. A. Grimm, R. J. Schmittling, et al.
A Novel Inhibitor of Signal Transducers And Activators Of Transcription 3 Activation Is Efficacious Against Established Central Nervous System Melanoma and Inhibits Regulatory T Cells
Clin. Cancer Res., September 15, 2008; 14(18): 5759 - 5768.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Takahashi, M. Takahashi, N. Carpino, S.-T. Jou, J.-R. Chao, S. Tanaka, Y. Shigeyoshi, E. Parganas, and J. N. Ihle
Leukemia Inhibitory Factor Regulates Trophoblast Giant Cell Differentiation via Janus Kinase 1-Signal Transducer and Activator of Transcription 3-Suppressor of Cytokine Signaling 3 Pathway
Mol. Endocrinol., July 1, 2008; 22(7): 1673 - 1681.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Y. W. Bourguignon, K. Peyrollier, W. Xia, and E. Gilad
Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells
J. Biol. Chem., June 20, 2008; 283(25): 17635 - 17651.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Snyder, X.-Y. Huang, and J. J. Zhang
Identification of Novel Direct Stat3 Target Genes for Control of Growth and Differentiation
J. Biol. Chem., February 15, 2008; 283(7): 3791 - 3798.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.